Skip to main content

Table 2 Multivariate analysis of overall and progression-free survival for HNSCC patients of the combined cohort

From: Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients

Risk factor

Overall Survival

Progression-Free Survival

 

HR (95 % CI)

p-value

HR (95 % CI)

p-value

KLK6

    
 

low vs. high1

2.793 (1.498–5.209)

0.001

2.236 (1.291–3.873)

0.004

Age [years]

    
 

<58.621 vs. ≥58.62

1.588 (0.892–2.825)

0.116

1.359 (0.811–2.277)

0.244

Gender

    
 

male1 vs. female

0.571 (0.268–1.219)

0.148

0.567 (0.281–1.143)

0.112

Clinical stage

    
 

I/II1 vs. III/IV

2.333 (0.892–6.104)

0.084

1.621 (0.724–3.629)

0.240

Pathological grade

    
 

G1/21 vs. G3

0.811 (0.431–1.527)

0.517

1.135 (0.648–1.987)

0.658

smoking

    
 

non-smoker1 vs. smoker2

1.701 (0.602–4.808)

0.317

2.831 (1.013–7.912)

0.047

Alcohol consumption

    
 

non-drinker1 vs. drinker3

0.911 (0.343–2.418)

0.852

1.056 (0.440–2.535)

0.903

  1. 1 variable set as reference; 2 former and current smokers; 3 former and current drinkers. Significant p-values (<0.05) are indicated in bold. HR hazard ratio, CI confidence interval